From: David Collette  
Sent: Monday, October 16, 2017 10:00 AM
To: Pharmacy
Subject: Emend shortage

Unfortunately, there is another important drug shortage to share...EMEND (aprepitant PO and fosaprepitant IV). The following e-mail went out to surgery leadership and all surgeons this morning:

Due to a manufacturing shortage, we are essentially out of Emend 40 mg capsules. Our wholesaler is also out of the 125 mg capsules, has 10 of the 80 mg capsules, and a limited supply of the injectable formulation.

It will be necessary to select an alternate product for prevention of post-op N/V (PONV) during this shortage. We will have a limited supply of the injectable product available for chemo-inducted N/V (CINV); otherwise, please reserve the use of the injectable product for CINV and highly-emetogenic surgeries, such as abdominal and GYN-related procedures. When indicated, the adult dose of the injectable product is 150 mg.

As soon as this shortage has resolved, we will update you.

--
David R. Collette, Pharm.D., FASHP
Operations Manager, Professional Services